9906 — Honliv Healthcare Management Co Share Price
Last trade - 00:00- HK$924.00m
- HK$842.52m
- CNY768.73m
- 75
- 45
- 13
- 40
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.51 | ||
| Price to Tang. Book | 1.52 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.13 | ||
| EV to EBITDA | 15.7 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.49% | ||
| Return on Equity | 5.59% | ||
| Operating Margin | 6.56% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 524.04 | 606.84 | 727.79 | 760.53 | 768.73 | n/a | n/a | 7.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -56.55 | -3.89 | +44.94 | -25.97 | -12.4 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Honliv Healthcare Management Group Co Ltd is an investment holding company principally engaged in the ownership, operation and management of hospitals. The Company, together with its subsidiaries, mainly provides treatment and general healthcare services and pharmaceutical sales. The Company's outpatient pharmaceutical treatment fields include the outpatient department, paediatrics, emergency department, haematology, obstetrics and gynaecology, dermatology, neurology, nails and breasts and preventive healthcare. The Company also engages in the provision of treatments and general healthcare services, including the sales of medical consumables and the provision of hospital ancillary services, and the sales of pharmaceuticals to patients, including both inpatients and outpatients. The Company mainly conducts its businesses in the domestic market and overseas markets.
Directors
- Yan Qin CHM (32)
- Jie Qi FID (38)
- Qingxiao Teng COO (54)
- Xiuzhi Hua VPR (51)
- Feng Qian VPR (50)
- Zhongtao Wang CTR (41)
- Yin Shan Hui SEC
- Xiaoyang Wang SEC (33)
- Hongchao Qin NED (34)
- Tianfan Jiang NID (39)
- Jigang Sun NID (52)
- Chun Zhao NID (67)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 1st, 2004
- Public Since
- July 10th, 2020
- No. of Employees
- 1,953
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 600,000,000
- Address
- No. 8, XINXIANG
- Web
- http://www.honlivhp.com/
- Phone
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 9906
Similar to 9906
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Beijing Health (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 21:08 UTC, shares in Honliv Healthcare Management Co are trading at HK$1.54. This share price information is delayed by 15 minutes.
Shares in Honliv Healthcare Management Co last closed at HK$1.54 and the price had moved by -38.89% over the past 365 days. In terms of relative price strength the Honliv Healthcare Management Co share price has underperformed the FTSE Developed Asia Pacific Index by -38.19% over the past year.
There is no consensus recommendation for this security.
Find out moreHonliv Healthcare Management Co does not currently pay a dividend.
Honliv Healthcare Management Co does not currently pay a dividend.
Honliv Healthcare Management Co does not currently pay a dividend.
To buy shares in Honliv Healthcare Management Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$1.54, shares in Honliv Healthcare Management Co had a market capitalisation of HK$924.00m.
Here are the trading details for Honliv Healthcare Management Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 9906
Based on an overall assessment of its quality, value and momentum Honliv Healthcare Management Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Honliv Healthcare Management Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -32.01%.
As of the last closing price of HK$1.54, shares in Honliv Healthcare Management Co were trading -22.18% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Honliv Healthcare Management Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.54.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Honliv Healthcare Management Co's management team is headed by:
- Yan Qin - CHM
- Jie Qi - FID
- Qingxiao Teng - COO
- Xiuzhi Hua - VPR
- Feng Qian - VPR
- Zhongtao Wang - CTR
- Yin Shan Hui - SEC
- Xiaoyang Wang - SEC
- Hongchao Qin - NED
- Tianfan Jiang - NID
- Jigang Sun - NID
- Chun Zhao - NID